740, Dr. Penfield Avenue, Room 7104
Montréal (Québec) Canada
Major funding for the McGill University and Génome Québec Innovation Centre is provided by the Government of Canada through Genome Canada, and also the ministère du Développement Économique, de l'Innovation et de l'Exportation of Québec.
The McGill University and Génome Québec Innovation Centre is a world class research facility for genomics and proteomics. Founded in 2002, the Centre has developed a world-renowned expertise in complex genetic disorders such as cardiac disease, asthma and Type 2 diabetes, and has become a resource and a networking site for various research initiatives in human health, forestry, infectious diseases, agriculture and environment.
Ambitious projects in recent years are a testimony of the ability of Génome Québec to provide data of exceptional quality in the pursuit of various genomics studies. The Innovation Centre provides complete DNA and RNA analysis services, from a few samples to several tens of thousands per week. Large-scale genomics and proteomics services at the Innovation Centre are articulated around sequencing (including massively parallel sequencing), genotyping, functional genomics and proteomics supported by a solid infrastructure, tools (Nanuq) and unique expertise in bioinformatics.
All services work in parallel to provide comprehensive, reliable services to the Québec, Canadian and international scientific community. Located on the campus of McGill University in the heart of Montreal, the Innovation Centre acts as a vast resource of knowledge and technology to the academic and industrial sectors.
The McGill University and Génome Québec Innovation Centre is proud to be supported by an international Scientific Advisory Board (iSAB).
Lon Cardon, PhD, FMedSci
Senior Vice President, Genetics and Quantitative Sciences
Expertise: Bioinformatics and quantitative; biology pharmaceutical applications
Professor Jonathan Knowles, PhD
Translational Medicine, EPFL, Switzerland Finnish Institute for Molecular Medicine, University of Helsinki, Finland Translational Medicine, University of Oxford, UK Vice Chairman and CSO of Caris Life Sciences Expertise: Translational medicine, diagnostics and pharmaceutical applications
Michel Georges, PhD Animal Genomics GIGA-R & Faculty of Veterinary Medicine University of Liège (B34) Belgium Expertise: Animal genetics, quantitative genetics and epigenomics
Professor Mathias Uhlen, PhD Royal Institute of Technology (KTH) Stockholm, Sweden Expertise: Genomic technologies and proteomics
Edison Liu, PhD Executive Director Genome Institute of Singapore Expertise: Genomic methodologies and cancer genomics
Dr. Mark Lathrop
Dr. Catalina Lopez-Correa (ex officio)
VP Scientific Affairs, Génome Québec
Dr. Naveed Aziz (ex officio)